This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

AboutCOVID-19Careers in pharmacologyNewsEventsEducation & engagementPartner with UsPublishingMembership & awardsOur CommunityMy BPS

Spotlight Commentary: How to prove pharmacology of immunomodulatory drugs in a phase 1 trial?

Article date: July 2019

By: Robert Rissmann, Elemer Szabadi in Volume 85, Issue 7, pages 1389-1390

DOI: 10.1111/bcp.13928

View this article

Publishing